Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: Addict Biol. 2021 Jan 3;26(4):e12993. doi: 10.1111/adb.12993

Table 4.

Frequency of side effects.

Outpatient Inpatient

Lorcaserin dose (mg BID) 0 10 0 10
Headache 1 (1) 3 (3) 1 (1) 5 (3)
Gastrointestinal upset 2 (2) 1 (1) 4 (4) 11 (6)
Fatigue 1 (1) 2 (2) 0 (0) 0 (0)
Body pain 0 (0) 0 (0) 1 (1) 1 (1)
Jittery/anxiety 0 (0) 1 (1) 1 (1) 1 (1)
Eye-dryness/discomfort 0 (0) 0 (0) 1 (1) 4 (2)
Trouble sleeping 0 (0) 0 (0) 0 (0) 2 (2)

Note: Data reflect the number of times each symptom was reported during the outpatient phase (2 days/dose) and inpatient phase (11 days/dose) as a function of lorcaserin dose; the number of participants reporting each symptom is in parentheses (max = 15).